She said: "It is important we consider the specific needs of
menopausal women and ensure that the workplace environment does not make their symptoms worse."
[ClickPress, Mon May 13 2019] This report on the
menopausal hot flashes market studies the current and future prospects of the treatment across the globe.
* Does the type of
menopausal HT used increase the risk of venous thromboembolism?
[USA], Jan 17 ( ANI ): A Mayo Clinic Study recently published in Climacteric: The Journal of the International Menopause Society now says that mindfulness maybe associated with fewer
menopausal symptoms for women.
The researchers found that across
menopausal stages,
menopausal symptoms, depression, and QOL worsened, especially in late perimenopausal women.
[1] Due to the complexity of
menopausal symptoms, many different alternatives have been developed to control these symptoms.
Visit the
Menopausal Hot Flashes Therapy Market 2013-2020 report https://www.ihealthcareanalyst.com/report/menopausal-hot-flashes-therapy-market/
With the prolongation of human life expectancy, females will spend more than one-third of their lifetime in
menopausal transition (MT) and the subsequent postmenopause (PM).
More and more clinicians, as well as more and more patients, are looking into safe and effective alternatives as a first-line intervention to alleviate
menopausal symptoms.
Lifestyle parameters like socio-economic status, age of menarche,
menopausal status, use of oral contraceptives, hormone replacement therapy, etc., were also evaluated.
Late age of natural menopause and use of
menopausal hormone therapy were associated with significantly increased risk of basal cell carcinoma (BCC), according to results of a large, nationwide cohort study.
Women who take a widely used class of antidepressants to ease
menopausal symptoms may face a long-term rise in their risk for bone fracture, a new study [Injury Prevention, June 25) suggests.
Menopausal hormone therapy is associated with an increased risk of major gastrointestinal bleeding, particularly in the lower gastrointestinal tract, that is associated with duration of use, a study has found.
